Vitamin D and Lung Outcomes in Elderly COVID-19 Patients
Overview
Authors
Affiliations
Vitamin D deficiency is frequently reported in patients with SARS-CoV-2 infection. The aim of this study was to correlate the 25OH-Vitamin D serum concentrations with clinical parameters of lung involvement, in elderly patients hospitalized for SARS-CoV-2 infection. Sixty-five consecutive COVID-19 patients (mean age 76 ± 13 years) and sixty-five sex- and age-matched control subjects (CNT) were analyzed. The following clinical parameters, including comorbidities, were collected at admission: type of pulmonary involvement, respiratory parameters (PaO, SO, PaCO, PaO/FiO), laboratory parameters (including 25OH-vitamin D, D-dimer, C-reactive protein). Significantly lower vitamin D serum levels were found in COVID-19 patients than in CNT (median 7.9 vs 16.3 ng/mL, = 0.001). Interestingly, a statistically significant positive correlation was observed between vitamin D serum levels and PaO ( = 0.03), SO ( = 0.05), PaO/FiO ( = 0.02), while a statistically significant negative correlation was found between vitamin D serum levels and D-dimer ( = 0.04), C-reactive protein ( = 0.04) and percentage of O in a venturi mask ( = 0.04). A negative correlation was also observed between vitamin D serum levels and severity of radiologic pulmonary involvement, evaluated by computed tomography: in particular, vitamin D was found significantly lower in COVID-19 patients with either multiple lung consolidations ( = 0.0001) or diffuse/severe interstitial lung involvement than in those with mild involvement ( = 0.05). Finally, significantly lower vitamin D serum levels were found in the elderly COVID-19 patients who died during hospitalization, compared to those who survived (median 3.0 vs 8.4 ng/mL, = 0.046). This study confirms that 25OH-vitamin D serum deficiency is associated with more severe lung involvement, longer disease duration and risk of death, in elderly COVID-19 patients. The detection of low vitamin D levels also in younger COVID-19 patients with less comorbidities further suggests vitamin D deficiency as crucial risk factor at any age.
Herbal and Dietary Supplements as Adjunctive Treatment for Mild SARS-CoV-2 Infection in Italy.
Licata A, Seidita A, Como S, de Carlo G, Cammilleri M, Bonica R Nutrients. 2025; 17(2).
PMID: 39861359 PMC: 11767322. DOI: 10.3390/nu17020230.
Comparison of the role of vitamin D in normal organs and those affected by COVID-19.
Peramaiyan R, Anthony J, Varalakshmi S, Sekar A, Ali E, A A Int J Med Sci. 2025; 22(2):240-251.
PMID: 39781525 PMC: 11704692. DOI: 10.7150/ijms.103260.
Vitamin D deficiency and duration of COVID-19 symptoms in UK healthcare workers.
Chadda K, Roberts S, Lugg S, Faniyi A, Faustini S, Webster C Front Med (Lausanne). 2024; 11:1494129.
PMID: 39655234 PMC: 11625565. DOI: 10.3389/fmed.2024.1494129.
Long-term effects of COVID-19 infection on bone mineral density.
Wang Z, Li Z, Shen Y, Qian S, Tang M, He J J Glob Health. 2024; 14:05029.
PMID: 39421935 PMC: 11487469. DOI: 10.7189/jogh.14.05029.
Chen J, Lu F, Shen B, Xu H, Chen Y, Hu Q Public Health Nutr. 2024; 27(1):e197.
PMID: 39370947 PMC: 11505208. DOI: 10.1017/S1368980024001873.